Capitaux D'Emprunt Changement Date
AstraZeneca USD 26.01B 46M 2026-06
Genmab DKK 5.14B 5.01B 2025-12
GlaxoSmithKline GBP 13.95B 65M 2026-06
GRIFOLS EUR 9.08B 612M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lakefront Biotherapeutics EUR 4.85M 335K 2026-03
Qiagen NV USD 1.65B 7.87M 2026-03
UCB EUR 2.18B 634M 2025-12